SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-07-080728
Filing Date
2007-11-07
Accepted
2007-11-07 16:37:40
Documents
3
Period of Report
2007-11-01
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a07-28768_18k.htm 8-K 36851
2 EX-99.1 a07-28768_1ex99d1.htm EX-99.1 5619
3 GRAPHIC g287681mai001.jpg GRAPHIC 5037
  Complete submission text file 0001104659-07-080728.txt   51344
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 071221967
SIC: 2835 In Vitro & In Vivo Diagnostic Substances